EUCTR2015-002230-41-IS进行中（未招募）1 期
Pharmacokinetics of Proton Pump Inhibitors in a random Icelandic Population.
andspitali University Hospital0 个研究点目标入组 30 人开始时间: 2015年6月5日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •We plan to recruit 30 healthy participants, with age 20 - 50 years, and equally many males and females.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •* Subjects taking known CYP (Cytochromes P450) inhibitors or inducers
- •* Known history of gastro oesophageal reflux symptoms
- •* Impaired hepatic and/or renal function
- •* Known H. pylori infection and/or other infectious diseases
- •* Known alcohol and/or substance abuse
- •* Pregnancy
- •* BMI > 30
研究者
相似试验
进行中（未招募）
4 期
Assessment of response to antacids in children with Eosinophilic EsophagitisEosinophilic EsophagitisRBR-2ntbth9Hospital Santa Casa de Misericórdia de Porto Alegre
已完成
不适用
Efficiency of Proton pump Inhibitors in Patients with gastro-oesophageal reflux symptomsGastro-oesophageal reflux diseaseDigestive SystemGI tract disordersISRCTN68985072Erasmus Medical Center (The Netherlands)415
尚未招募
不适用
A study on the effect of proton pump inhibitors on the intragastric pH for the patients of functional dysplasiaFunctional dyspepsia(FD)JPRN-UMIN000003127FD-pH Society60
已完成
不适用
Proton pump inhibitors, oral and injectable, in preventing peptic ulcer re-bleedinggastroduodenal ulcer.Peptic ulcer, site unspecifiedIRCT2014082515510N2Vice Chancellor for research of Mazandaran University of Medical Sciences260
已完成
不适用
The influence of proton pump inhibitor therapy on the clinical course of COVID-19SARS-CoV2J12.8J80.0Other viral pneumoniaDRKS00021523niversitätsklinikum Freiburg, Klinik für Innere Medizin II152